Symbol="ACRX"
AssetType="Common Stock"
Name="AcelRx Pharmaceuticals Inc"
Description="AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. The company is headquartered in Redwood City, California."
CIK="1427925"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="351 GALVESTON DRIVE, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="11689000"
EBITDA="-30424000"
PERatio="0.194"
PEGRatio="0"
BookValue="1.304"
DividendPerShare="0"
DividendYield="0"
EPS="5.51"
RevenuePerShareTTM="0.214"
ProfitMargin="24.2"
OperatingMarginTTM="-18.11"
ReturnOnAssetsTTM="-0.408"
ReturnOnEquityTTM="0"
RevenueTTM="1771000"
GrossProfitTTM="-5030000"
DilutedEPSTTM="5.51"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="125"
AnalystTargetPrice="4"
TrailingPE="0.194"
ForwardPE="1.06"
PriceToSalesRatioTTM="11.8"
PriceToBookRatio="0.69"
EVToRevenue="10.28"
EVToEBITDA="0.309"
Beta="0.261"
num_52WeekHigh="7.6"
num_52WeekLow="0.55"
num_50DayMovingAverage="1.048"
num_200DayMovingAverage="1.721"
SharesOutstanding="10924300"
DividendDate="None"
ExDividendDate="None"
symbol="ACRX"
open="1.08"
high="1.08"
low="0.99"
price="1.02"
volume="140984.00"
latest_trading_day="2023-07-21"
previous_close="1.07"
change="-0.05"
change_percent="-4.6729%"
aroon_positive_momentum_days="34"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="34"
Volume_recent_avg="185848"
Change_recent_avg="-0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-1.16"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="34"
Aroon_momentum_negative="66"
image_negative_thumbnail_id_1="1091"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0124.jpeg"
image_negative_thumbnail_id_2="1153"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0186.jpeg"
image_neutral_thumbnail_id_1="583"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_neutral_thumbnail_id_2="530"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0069.jpeg"
image_positive_thumbnail_id_1="684"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0024.jpeg"
image_positive_thumbnail_id_2="988"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0150.jpeg"
image_professor_thumbnail_id_1="1171"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
